Nigeria In-Vitro Diagnostics (IVD) Market to Surpass USD 48 Million by 2031

Published | 14 October 2025

Nigeria In-Vitro Diagnostics (IVD) Market is flourishing because of the increasing prevalence of infectious and chronic diseases and the rapid adoption of innovations in IVD technology, such as point-of-care (PoC) testing, molecular diagnostics, and automation.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Nigeria In-Vitro Diagnostics (IVD) Market size at USD 37.12 million in 2024. During the forecast period between 2025 and 2031, BlueWeave expects Nigeria In-Vitro Diagnostics (IVD) Market size to expand at a steady CAGR of 3.74% reaching a value of USD 48.01 million by 2031. Increasing incidences of both communicable and non-communicable diseases are key drivers of Nigeria In-Vitro Diagnostics (IVD) Market. The number of point-of-care (PoC) tests is also rising along with the use of automation in labs and automated equipment. It, in turn, is expected to provide significant growth opportunities for the players in Nigeria In-Vitro Diagnostics (IVD) Market.

Opportunity - Automation in IVD labs

Growing adoption of automated instruments and automation in laboratories is forecast to present lucrative growth opportunities for the players in Nigeria In-Vitro Diagnostics (IVD) Market in the coming years. Automated instruments provide several benefits, such as higher performance levels, enhanced productivity, data accuracy, and meeting safety protocols. As a result, the market players are developing and launching automated instruments that offer higher efficiency and effectiveness in IVD tests. The increasing test volumes and shortage of skilled lab personnel are expected to boost automation in laboratories.

Sample Request:https://www.blueweaveconsulting.com/report/nigeria-in-vitro-diagnostics-ivd-market/report-sample

Hospitals Dominate Nigeria In-Vitro Diagnostics (IVD) Market

The increasing number of hospital facilities and their dependence on IVD for diagnosis and treatment decisions fuel the demand for in-vitro diagnostic (IVD) tests. The high rate of in-patient and out-patient treatment in hospitals due to the presence of advanced diagnostic setups further contributes to the segment growth. Hence, the hospital segment dominates Nigeria In-Vitro Diagnostics (IVD) Market by end user. Meanwhile, the point-of-care (PoC) segment is also expected to grow at a high rate over the forecast period. Other major end user segments in Nigeria In-Vitro Diagnostics (IVD) Market include standalone laboratories, and academic & medical schools.

Impact of Escalating Geopolitical Tensions on Nigeria In-Vitro Diagnostics (IVD) Market

Escalating geopolitical tensions could disrupt the growth of Nigeria In-Vitro Diagnostics (IVD) Market. For example, China is a significant exporter of medical diagnostic test equipment. Additionally, geopolitical conflicts affect supply chains, making healthcare supplies harder to get and ultimately leading to price increases that might affect the growth of Nigeria Market for In-Vitro Diagnostics (IVD).

Competitive Landscape

Nigeria In-Vitro Diagnostics (IVD) market is intensely competitive, as a number of companies are competing to gain a significant market share. Key players in the market include Abbott Laboratories, Afrigold Medicure, Becton, Dickinson and Company, bioMérieux, Danaher Corporation, Me Cure Healthcare, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, and Union Diagnostics and Clinical Service PLC. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Don’t miss the business opportunity in Nigeria In-Vitro Diagnostics (IVD) Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and Nigeria In-Vitro Diagnostics (IVD) Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Nigeria In-Vitro Diagnostics (IVD) Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

About Us

BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing qualitative and quantitative data to boost the performance of your business solutions. BlueWeave has built its reputation by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.

Contact Us:

BlueWeave Consulting & Research Pvt Ltd

+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662

info@blueweaveconsulting.com